{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T16:08:44Z","timestamp":1768925324945,"version":"3.49.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2015,4,21]],"date-time":"2015-04-21T00:00:00Z","timestamp":1429574400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1007\/s00417-015-3008-0","type":"journal-article","created":{"date-parts":[[2015,4,19]],"date-time":"2015-04-19T22:52:50Z","timestamp":1429483970000},"page":"1111-1119","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Adverse effects of low-dose systemic cyclosporine therapy in high-risk penetrating keratoplasty"],"prefix":"10.1007","volume":"253","author":[{"given":"Jong Joo","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mee Kum","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Won Ryang","family":"Wee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,4,21]]},"reference":[{"key":"3008_CR1","series-title":"3rd edn","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/B978-0-323-06387-6.00135-5","volume-title":"Cornea","author":"P Hamrah","year":"2011","unstructured":"Hamrah P, Mantopoulos D, Akhtar J, Djalilian AR (2011) Immunologically high-risk penetrating keratoplasty. In: Krachmer JH, Mannis MJ, Holland EJ (eds) Cornea, vol 2, 3rd edn. Elsevier\/Mosby, Philadelphia, pp 1495\u20131509"},{"key":"3008_CR2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/978-3-540-85544-6_3","volume-title":"Cornea and external eye disease","author":"A Reis","year":"2010","unstructured":"Reis A, Reinhard T (2010) New developments in topical and systemic immunomodulation following penetrating keratoplasty. In: Reinhard T, Larkin F (eds) Cornea and external eye disease. Springer, Germany, pp 25\u201337"},{"issue":"1","key":"3008_CR3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3109\/09273949609069123","volume":"4","author":"RJ Uusitalo","year":"1996","unstructured":"Uusitalo RJ, Mahlberg K, Krootila K, Ruusuvaara P (1996) Systemic cyclosporin treatment for high-risk corneal transplantation. Ocul Immunol Inflamm 4(1):15\u201324. doi: 10.3109\/09273949609069123","journal-title":"Ocul Immunol Inflamm"},{"issue":"Pt 4","key":"3008_CR4","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/eye.1995.99","volume":"9","author":"JC Hill","year":"1995","unstructured":"Hill JC (1995) Systemic cyclosporine in high-risk keratoplasty: long-term results. Eye (Lond) 9(Pt 4):422\u2013428. doi: 10.1038\/eye.1995.99","journal-title":"Eye (Lond)"},{"issue":"1","key":"3008_CR5","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0161-6420(13)31253-6","volume":"101","author":"JC Hill","year":"1994","unstructured":"Hill JC (1994) Systemic cyclosporine in high-risk keratoplasty. Short- versus long-term therapy. Ophthalmology 101(1):128\u2013133","journal-title":"Ophthalmology"},{"issue":"3","key":"3008_CR6","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10792-007-9099-9","volume":"28","author":"EM Chong","year":"2008","unstructured":"Chong EM, Dana MR (2008) Graft failure IV. Immunologic mechanisms of corneal transplant rejection. Int Ophthalmol 28(3):209\u2013222. doi: 10.1007\/s10792-007-9099-9","journal-title":"Int Ophthalmol"},{"issue":"Suppl 1","key":"3008_CR7","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1007\/BF02343059","volume":"234","author":"T Reinhard","year":"1996","unstructured":"Reinhard T, Sundmacher R, Heering P (1996) Systemic ciclosporin A in high-risk keratoplasties. Graefes Arch Clin Exp Ophthalmol 234(Suppl 1):S115\u2013S121","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"12","key":"3008_CR8","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1136\/bjo.85.12.1464","volume":"85","author":"AC Poon","year":"2001","unstructured":"Poon AC, Forbes JE, Dart JK, Subramaniam S, Bunce C, Madison P, Ficker LA, Tuft SJ, Gartry DS, Buckley RJ (2001) Systemic cyclosporin A in high risk penetrating keratoplasties: a case-control study. Br J Ophthalmol 85(12):1464\u20131469","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"3008_CR9","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0021-5155(01)00339-2","volume":"45","author":"K Inoue","year":"2001","unstructured":"Inoue K, Kimura C, Amano S, Sato T, Fujita N, Kagaya F, Kaji Y, Tsuru T, Araie M (2001) Long-term outcome of systemic cyclosporine treatment following penetrating keratoplasty. Jpn J Ophthalmol 45(4):378\u2013382","journal-title":"Jpn J Ophthalmol"},{"issue":"9","key":"3008_CR10","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1136\/bjo.86.9.988","volume":"86","author":"S Rumelt","year":"2002","unstructured":"Rumelt S, Bersudsky V, Blum-Hareuveni T, Rehany U (2002) Systemic cyclosporin A in high failure risk, repeated corneal transplantation. Br J Ophthalmol 86(9):988\u2013992","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"3008_CR11","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ajo.2011.01.019","volume":"152","author":"J Shimazaki","year":"2011","unstructured":"Shimazaki J, Den S, Omoto M, Satake Y, Shimmura S, Tsubota K (2011) Prospective, randomized study of the efficacy of systemic cyclosporine in high-risk corneal transplantation. Am J Ophthalmol 152(1):33\u201339. doi: 10.1016\/j.ajo.2011.01.019 , e1","journal-title":"Am J Ophthalmol"},{"key":"3008_CR12","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/B978-0-323-06387-6.00163-X","volume-title":"Cornea","author":"AR Djalilian","year":"2011","unstructured":"Djalilian AR, Bhasin AK, Holland EJ (2011) Postoperative management of ocular surface reconstruction. In: Krachmer JH, Mannis MJ, Holland EJ (eds) Cornea, 3rd edn. Elsevier\/Mosby, Philadelphia, pp 1745\u20131753","edition":"3"},{"issue":"8","key":"3008_CR13","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1097\/01.TP.0000158022.62059.F2","volume":"79","author":"F Birnbaum","year":"2005","unstructured":"Birnbaum F, Bohringer D, Sokolovska Y, Sundmacher R, Reinhard T (2005) Immunosuppression with Cyclosporine A and mycophenolate mofetil after penetrating high-risk keratoplasty: a retrospective study. Transplantation 79(8):964\u2013968. doi: 10.1097\/01.tp.0000158022.62059.f2","journal-title":"Transplantation"},{"issue":"12","key":"3008_CR14","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1097\/ICO.0b013e31821e65b3","volume":"30","author":"AK Maier","year":"2011","unstructured":"Maier AK, Ozlugedik S, Rottler J, Heussen FM, Klamann MK, Huber KK, Joussen AM, Winterhalter S (2011) Efficacy of postoperative immunosuppression after keratoplasty in herpetic keratitis. Cornea 30(12):1398\u20131405. doi: 10.1097\/ICO.0b013e31821e65b3","journal-title":"Cornea"},{"issue":"8","key":"3008_CR15","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1097\/ICO.0b013e3180e79b77","volume":"26","author":"DD Garcia","year":"2007","unstructured":"Garcia DD, Farjo Q, Musch DC, Sugar A (2007) Effect of prophylactic oral acyclovir after penetrating keratoplasty for herpes simplex keratitis. Cornea 26(8):930\u2013934. doi: 10.1097\/ICO.0b013e3180e79b77","journal-title":"Cornea"},{"issue":"8","key":"3008_CR16","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1097\/ICO.0b013e318198399a","volume":"28","author":"AF Jansen","year":"2009","unstructured":"Jansen AF, Rijneveld WJ, Remeijer L, Volker-Dieben HJ, Eggink CA, Geerards AJ, Mulder PG, van Rooij J (2009) Five-year follow-up on the effect of oral acyclovir after penetrating keratoplasty for herpetic keratitis. Cornea 28(8):843\u2013845. doi: 10.1097\/ICO.0b013e318198399a","journal-title":"Cornea"},{"issue":"1","key":"3008_CR17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1600-0420.1995.tb00008.x","volume":"73","author":"JA Lomholt","year":"1995","unstructured":"Lomholt JA, Baggesen K, Ehlers N (1995) Recurrence and rejection rates following corneal transplantation for herpes simplex keratitis. Acta Ophthalmol Scand 73(1):29\u201332","journal-title":"Acta Ophthalmol Scand"},{"issue":"4","key":"3008_CR18","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3949\/ccjm.61.4.308","volume":"61","author":"RM Graham","year":"1994","unstructured":"Graham RM (1994) Cyclosporine: mechanisms of action and toxicity. Cleve Clin J Med 61(4):308\u2013313","journal-title":"Cleve Clin J Med"},{"issue":"19","key":"3008_CR19","doi-asserted-by":"crossref","first-page":"9678","DOI":"10.1128\/JVI.01159-08","volume":"82","author":"AJ Johnson","year":"2008","unstructured":"Johnson AJ, Chu CF, Milligan GN (2008) Effector CD4+ T-cell involvement in clearance of infectious herpes simplex virus type 1 from sensory ganglia and spinal cords. J Virol 82(19):9678\u20139688. doi: 10.1128\/JVI. 01159-08","journal-title":"J Virol"},{"issue":"7272","key":"3008_CR20","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/nature08511","volume":"462","author":"Y Nakanishi","year":"2009","unstructured":"Nakanishi Y, Lu B, Gerard C, Iwasaki A (2009) CD8(+) T lymphocyte mobilization to virus-infected tissue requires CD4(+) T-cell help. Nature 462(7272):510\u2013513. doi: 10.1038\/nature08511","journal-title":"Nature"},{"issue":"5","key":"3008_CR21","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s004170100285","volume":"239","author":"T Reinhard","year":"2001","unstructured":"Reinhard T, Reis A, B\u00f6hringer D, Malinowski M, Voiculescu A, Heering P, Godehardt E, Sundmacher R (2001) Systemic mycophenolate mofetil in comparison with systemic cyclosporin A in high-risk keratoplasty patients: 3 years\u2019 results of a randomized prospective clinical trial. Graefes Arch Clin Exp Ophthalmol 239(5):367\u2013372. doi: 10.1007\/s004170100285","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"11","key":"3008_CR22","doi-asserted-by":"crossref","first-page":"121S","DOI":"10.1016\/0895-7061(96)00288-9","volume":"9","author":"M Sander","year":"1996","unstructured":"Sander M, Lyson T, Thomas GD, Victor RG (1996) Sympathetic neural mechanisms of cyclosporine-induced hypertension. Am J Hypertens 9(11):121S\u2013138S","journal-title":"Am J Hypertens"},{"issue":"5","key":"3008_CR23","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2165\/00002018-199920050-00004","volume":"20","author":"SJ Taler","year":"1999","unstructured":"Taler SJ, Textor SC, Canzanello VJ, Schwartz L (1999) Cyclosporin-induced hypertension: incidence, pathogenesis and management. Drug Saf 20(5):437\u2013449","journal-title":"Drug Saf"},{"issue":"6 Suppl 6","key":"3008_CR24","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1053\/ajkd.2001.28923","volume":"38","author":"RS Gaston","year":"2001","unstructured":"Gaston RS (2001) Maintenance immunosuppression in the renal transplant recipient: an overview. Am J Kidney Dis 38(6 Suppl 6):S25\u2013S35","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"3008_CR25","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1097\/01.ASN.0000034945.61533.26","volume":"13","author":"C Isnard Bagnis","year":"2002","unstructured":"Isnard Bagnis C, Tezenas du Montcel S, Beaufils H, Jouanneau C, Jaudon MC, Maksud P, Mallet A, LeHoang P, Deray G (2002) Long-term renal effects of low-dose cyclosporine in uveitis-treated patients: follow-up study. J Am Soc Nephrol 13(12):2962\u20132968","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"3008_CR26","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2215\/CJN.04800908","volume":"4","author":"M Naesens","year":"2009","unstructured":"Naesens M, Kuypers DR, Sarwal M (2009) Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol 4(2):481\u2013508. doi: 10.2215\/CJN.04800908","journal-title":"Clin J Am Soc Nephrol"},{"key":"3008_CR27","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/230386","volume":"2012","author":"D Tedesco","year":"2012","unstructured":"Tedesco D, Haragsim L (2012) Cyclosporine: a review. J Transplant 2012, 230386. doi: 10.1155\/2012\/230386","journal-title":"J Transplant"},{"issue":"5","key":"3008_CR28","first-page":"565","volume":"27","author":"J Perez de Hornedo","year":"2007","unstructured":"Perez de Hornedo J, de Arriba G, Calvino M, Benito S, Parra T (2007) Cyclosporin A causes oxidative stress and mitochondrial dysfunction in renal tubular cells. Nefrologia 27(5):565\u2013573","journal-title":"Nefrologia"},{"issue":"6","key":"3008_CR29","first-page":"743","volume":"78","author":"CA Naughton","year":"2008","unstructured":"Naughton CA (2008) Drug-induced nephrotoxicity. Am Fam Physician 78(6):743\u2013750","journal-title":"Am Fam Physician"},{"issue":"5","key":"3008_CR30","doi-asserted-by":"crossref","first-page":"372","DOI":"10.7555\/JBR.26.20110067","volume":"26","author":"W Xu","year":"2012","unstructured":"Xu W, Fan W, Yao K (2012) Cyclosporine A stimulated hair growth from mouse vibrissae follicles in an organ culture model. J Biomed Res 26(5):372\u2013380. doi: 10.7555\/JBR.26.20110067","journal-title":"J Biomed Res"},{"issue":"6","key":"3008_CR31","doi-asserted-by":"crossref","first-page":"C1593","DOI":"10.1152\/ajpcell.00537.2002","volume":"284","author":"A Gafter-Gvili","year":"2003","unstructured":"Gafter-Gvili A, Sredni B, Gal R, Gafter U, Kalechman Y (2003) Cyclosporin A-induced hair growth in mice is associated with inhibition of calcineurin-dependent activation of NFAT in follicular keratinocytes. Am J Physiol Cell Physiol 284(6):C1593\u20131603. doi: 10.1152\/ajpcell.00537.2002","journal-title":"Am J Physiol Cell Physiol"},{"issue":"3","key":"3008_CR32","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s13181-010-0075-9","volume":"6","author":"K Weibrecht","year":"2010","unstructured":"Weibrecht K, Dayno M, Darling C, Bird SB (2010) Liver aminotransferases are elevated with rhabdomyolysis in the absence of significant liver injury. J Med Toxicol 6(3):294\u2013300. doi: 10.1007\/s13181-010-0075-9","journal-title":"J Med Toxicol"},{"issue":"4","key":"3008_CR33","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/09273940701375147","volume":"15","author":"A Lasocki","year":"2007","unstructured":"Lasocki A, Vote B, Fassett R, Zamir E (2007) Simvastatin-induced rhabdomyolysis following cyclosporine treatment for uveitis. Ocul Immunol Inflamm 15(4):345\u2013346. doi: 10.1080\/09273940701375147","journal-title":"Ocul Immunol Inflamm"},{"issue":"5","key":"3008_CR34","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1345\/aph.1A058","volume":"36","author":"JL Maxa","year":"2002","unstructured":"Maxa JL, Melton LB, Ogu CC, Sills MN, Limanni A (2002) Rhabdomyolysis after concomitant use of cyclosporine, simvastatin, gemfibrozil, and itraconazole. Ann Pharmacother 36(5):820\u2013823","journal-title":"Ann Pharmacother"},{"issue":"12","key":"3008_CR35","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1007\/s00347-003-0954-4","volume":"100","author":"U Pleyer","year":"2003","unstructured":"Pleyer U (2003) Immunomodulation in penetrating keratoplasty. Current status and perspectives. Ophthalmologe 100(12):1036\u20131044. doi: 10.1007\/s00347-003-0954-4","journal-title":"Ophthalmologe"},{"issue":"11","key":"3008_CR36","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1038\/eye.2008.402","volume":"23","author":"F Birnbaum","year":"2009","unstructured":"Birnbaum F, Mayweg S, Reis A, Bohringer D, Seitz B, Engelmann K, Messmer EM, Reinhard T (2009) Mycophenolate mofetil (MMF) following penetrating high-risk keratoplasty: long-term results of a prospective, randomised, multicentre study. Eye (Lond) 23(11):2063\u20132070. doi: 10.1038\/eye.2008.402","journal-title":"Eye (Lond)"},{"issue":"2","key":"3008_CR37","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ajo.2010.03.010","volume":"150","author":"MA Chatel","year":"2010","unstructured":"Chatel MA, Larkin DF (2010) Sirolimus and mycophenolate as combination prophylaxis in corneal transplant recipients at high rejection risk. Am J Ophthalmol 150(2):179\u2013184. doi: 10.1016\/j.ajo.2010.03.010","journal-title":"Am J Ophthalmol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-015-3008-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-015-3008-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-015-3008-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T15:55:59Z","timestamp":1566575759000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-015-3008-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,21]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["3008"],"URL":"https:\/\/doi.org\/10.1007\/s00417-015-3008-0","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,21]]}}}